Canadian Online Pharmacy

CDER New July 14, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

July 11, 2014


New and Generic Drug Approvals

July 10, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Anafranil clomipramine hydrochloride Capsule;Oral Mallinckrodt Llc Labeling Revision
Docetaxel docetaxel Injectable;Injection Hospira Inc Efficacy Supplement with Clinical Data to Support
Namenda memantine hydrochloride Solution;Oral Forest Labs Manufacturing Change or Addition
Pamelor nortriptyline hydrochloride Solution;Oral Mallinckrodt Inc Labeling Revision
Pamelor nortriptyline hydrochloride Capsule;Oral Mallinckrodt Llc Labeling Revision
Pennsaid diclofenac sodium Solution;Topical Mallinckrodt Inc Manufacturing Change or Addition
Qnasl beclomethasone dipropionate Aerosol, Metered;Nasal Teva Branded Pharm Labeling Revision
Rasuvo methotrexate Injectable;Injection Medac Pharma Inc Approval
Rescula unoprostone isopropyl Solution/Drops;Ophthalmic Sucampo Pharms Manufacturing Change or Addition
Tofranil-Pm imipramine pamoate Capsule;Oral Mallinckrodt Inc Labeling Revision

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery